Home » Stocks » PRTX

Protalex, Inc. (PRTX)

Stock Price: $0.0076 USD 0.0000 (0.00%)
Updated Jan 7, 2021 9:30 AM EST - Market closed
Market Cap 473
Revenue (ttm) n/a
Net Income (ttm) -4.65M
Shares Out 47.33M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 7
Last Price $0.0076
Previous Close $0.0000
Change ($) 0.0000
Change (%) 0.00%
Day's Open -
Day's Range 0.0003 - 0.0076
Day's Volume 0
52-Week Range 0.0001 - 0.0100

News

There are no news available yet.

About PRTX

Protalex focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of pati... [Read more...]

Industry
Drug Manufacturers - Other
IPO Date
Jan 11, 2000
Stock Exchange
OTCMKTS
Ticker Symbol
PRTX
Full Company Profile

Financial Performance

Financial Statements